Authors: Horig, H Lee, DS Conkright, W Divito, J Hasson, H LaMare, M Rivera, A Park, D Tine, J Guito, K Tsang, KWY Schlom, J Kaufman, HL

Citation: H. Horig et al., Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule, CANCER IMMU, 49(9), 2000, pp. 504-514